Resmed Inc Stock Filter Stocks by Fundamentals
RME Stock | EUR 222.30 3.30 1.51% |
Fundamental analysis of ResMed allows traders to better anticipate movements in ResMed's stock price by examining its financial health and performance throughout various phases of its business cycle.
ResMed |
Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
All Next | Launch Module |
ResMed Fundamentals
Return On Equity | 0.24 | |||
Return On Asset | 0.12 | |||
Profit Margin | 0.22 % | |||
Operating Margin | 0.28 % | |||
Current Valuation | 31.17 B | |||
Shares Outstanding | 146.91 M | |||
Shares Owned By Insiders | 1.29 % | |||
Shares Owned By Institutions | 66.53 % | |||
Price To Earning | 41.49 X | |||
Price To Book | 9.40 X | |||
Price To Sales | 8.54 X | |||
Revenue | 3.58 B | |||
Gross Profit | 2.06 B | |||
EBITDA | 1.19 B | |||
Net Income | 779.44 M | |||
Cash And Equivalents | 147.13 M | |||
Cash Per Share | 1.03 X | |||
Total Debt | 765.33 M | |||
Debt To Equity | 61.30 % | |||
Current Ratio | 2.06 X | |||
Book Value Per Share | 25.45 X | |||
Cash Flow From Operations | 351.15 M | |||
Earnings Per Share | 5.17 X | |||
Price To Earnings To Growth | 1.74 X | |||
Target Price | 261.67 | |||
Number Of Employees | 8.16 K | |||
Beta | 0.47 | |||
Market Capitalization | 29.28 B | |||
Total Asset | 5.1 B | |||
Z Score | 22.8 | |||
Annual Yield | 0.01 % | |||
Five Year Return | 1.34 % | |||
Net Asset | 5.1 B | |||
Last Dividend Paid | 1.72 |
About ResMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ResMed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in ResMed Stock
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.